Human SARS-CoV-2 Nucleocapsid IgG (SARS-CoV-2 N IgG) ELISA Kit |
abx395203-100l |
Abbexa |
100 µl |
EUR 687.5 |
Human IgG antibody Laboratories manufactures the the sars-cov kit diagnosis reagents distributed by Genprice. The The Sars-Cov Kit Diagnosis reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Kit. Other The products are available in stock. Specificity: The Category: Sars-Cov Group: Kit Diagnosis
SARS-CoV-2 Nucleoprotein IgG Antibody ELISA Kit |
Biovision |
96 assays |
EUR 1268.4 |
SARS-CoV-2 IgG/IgM Antibody ELISA Kit |
Abclonal |
96T |
EUR 467.61 |
SARS-CoV-2 Human IgG Assay Control |
Genovis AB |
1 mL |
EUR 105 |
SARS-COV-2 IgG ELISA Kit (Quantitative) |
Creative Diagnostics |
96T |
EUR 1039.92 |
Description: Serum, plasma |
*SARS-CoV-2 IgG Seroconversion ELISA Kit |
Innovative research |
each |
EUR 198 |
|
Description: *SARS-CoV-2 IgG Seroconversion ELISA Kit |
SARS-CoV-2 IgG Agile ELISA Kit |
Genovis AB |
96 Tests |
EUR 1025 |
SARS-CoV-2 IgG Seroconversion ELISA Kit |
MyBiosource |
1Kit |
EUR 345 |
Kit Diagnosis information
Mouse Anti SARS-CoV-2 Nucleoprotein Antibody (JA6) |
MAB12467-100 |
The Native Antigen Company |
0.1 |
EUR 279.39 |
Description: Mouse monoclonal antibody against SARS-CoV-2 nucleoprotein. |
Mouse Anti SARS-CoV-2 Nucleoprotein Antibody (JA6) |
MAB12467-500 |
The Native Antigen Company |
0.5 |
EUR 695.29 |
Description: Mouse monoclonal antibody against SARS-CoV-2 nucleoprotein. |
Mouse Anti SARS-CoV-2 Nucleoprotein Antibody (JF1) |
MAB12468-100 |
The Native Antigen Company |
0.1 |
EUR 279.39 |
Description: Mouse monoclonal antibody against SARS-CoV-2 nucleoprotein. |
Mouse Anti SARS-CoV-2 Nucleoprotein Antibody (JF1) |
MAB12468-500 |
The Native Antigen Company |
0.5 |
EUR 695.29 |
Description: Mouse monoclonal antibody against SARS-CoV-2 nucleoprotein. |
Mouse Anti SARS-CoV-2 Nucleoprotein Antibody (GC12) |
MAB12465-100 |
The Native Antigen Company |
0.1 |
EUR 279.39 |
Description: Mouse monoclonal antibody against SARS-CoV-2 nucleoprotein. |
Mouse Anti SARS-CoV-2 Nucleoprotein Antibody (GC12) |
MAB12465-500 |
The Native Antigen Company |
0.5 |
EUR 695.29 |
Description: Mouse monoclonal antibody against SARS-CoV-2 nucleoprotein. |
SARS-CoV-2 Spike Protein Neutralizing Nanobody (L14) |
MAB12473-100 |
The Native Antigen Company |
0.1 |
EUR 727.47 |
Description: Recombinant Llama VHH Antibody for studying neutralization of SARS-CoV-2 and detection of Spike glycoprotein. Neutralizing activity validated for wild type Spike protein RBD , Spike protein RBD (N501Y) variant, and triple mutant (K417N, E484K, N501Y) RBD. |
SARS-CoV-2 Spike Protein Neutralizing Nanobody (L14) |
MAB12473-20 |
The Native Antigen Company |
0.02 |
EUR 370.82 |
Description: Recombinant Llama VHH Antibody for studying neutralization of SARS-CoV-2 and detection of Spike glycoprotein. Neutralizing activity validated for wild type Spike protein RBD , Spike protein RBD (N501Y) variant, and triple mutant (K417N, E484K, N501Y) RBD. |
SARS-CoV-2 Spike Protein Neutralizing Nanobody (L25) |
MAB12474-100 |
The Native Antigen Company |
0.1 |
EUR 727.47 |
Description: Recombinant Llama VHH Antibody for studying neutralization of SARS-CoV-2 and detection of Spike glycoprotein. Neutralizing activity validated for wild type Spike protein RBD. |
SARS-CoV-2 Spike Protein Neutralizing Nanobody (L25) |
MAB12474-20 |
The Native Antigen Company |
0.02 |
EUR 370.82 |
Description: Recombinant Llama VHH Antibody for studying neutralization of SARS-CoV-2 and detection of Spike glycoprotein. Neutralizing activity validated for wild type Spike protein RBD. |
SARS-CoV-2 Spike Protein Neutralizing Nanobody (L38) |
MAB12475-100 |
The Native Antigen Company |
0.1 |
EUR 727.47 |
Description: Recombinant Llama VHH Antibody for studying neutralization of SARS-CoV-2 and detection of Spike glycoprotein. Neutralizing activity validated for wild type Spike protein RBD and RBD (N501Y) variants. |
SARS-CoV-2 Spike Protein Neutralizing Nanobody (L38) |
MAB12475-20 |
The Native Antigen Company |
0.02 |
EUR 370.82 |
Description: Recombinant Llama VHH Antibody for studying neutralization of SARS-CoV-2 and detection of Spike glycoprotein. Neutralizing activity validated for wild type Spike protein RBD and RBD (N501Y) variants. |
SARS-CoV-2 Spike Protein Neutralizing Nanobody (HL14) |
MAB12469-100 |
The Native Antigen Company |
0.1 |
EUR 727.47 |
Description: Recombinant Llama VHH-Human IgG Antibody for studying neutralization of SARS-CoV-2 and detection of Spike glycoprotein. Neutralizing activity validated for wild type Spike protein RBD and Spike protein RBD (N501Y) variant. |
SARS-CoV-2 Spike Protein Neutralizing Nanobody (HL14) |
MAB12469-20 |
The Native Antigen Company |
0.02 |
EUR 370.82 |
Description: Recombinant Llama VHH-Human IgG Antibody for studying neutralization of SARS-CoV-2 and detection of Spike glycoprotein. Neutralizing activity validated for wild type Spike protein RBD and Spike protein RBD (N501Y) variant. |
SARS-CoV-2 Spike Protein Neutralizing Nanobody (HL25) |
MAB12470-100 |
The Native Antigen Company |
0.1 |
EUR 727.47 |
Description: Recombinant Llama VHH-Human IgG Antibody for studying neutralization of SARS-CoV-2 and detection of Spike glycoprotein. Neutralizing activity validated for wild type Spike protein RBD. |
SARS-CoV-2 Spike Protein Neutralizing Nanobody (HL25) |
MAB12470-20 |
The Native Antigen Company |
0.02 |
EUR 370.82 |
Description: Recombinant Llama VHH-Human IgG Antibody for studying neutralization of SARS-CoV-2 and detection of Spike glycoprotein. Neutralizing activity validated for wild type Spike protein RBD. |
SARS-CoV-2 Spike Protein Neutralizing Nanobody (HL38) |
MAB12471-100 |
The Native Antigen Company |
0.1 |
EUR 727.47 |
Description: Recombinant Llama VHH-Human IgG Antibody for studying neutralization of SARS-CoV-2 and detection of Spike glycoprotein. Neutralizing activity validated for wild type Spike protein RBD and Spike protein RBD (N501Y) variant. |